GlassScriptPhysician profile
Stephen D Wood
NPI 1508881657
$1,285.15
in general payments reported to CMS, 2019-2025
16 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $67.91 · 2021: $69.87 · 2022: $164 · 2023: $352 · 2024: $254 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $818.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $697.32 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Abbott Laboratories | $191.19 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Novartis Pharmaceuticals Corporation | $64.05 | 2022-2023 | |
| Amgen INC. | $60.08 | 2019-2020 | |
| Pfizer INC. | $53.96 | 2019-2025 | |
| Quidel Corporation | $40.84 | 2019 | |
| Allergan, INC. | $40.13 | 2019-2020 | |
| Dexcom, INC. | $19.99 | 2024 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $16.92 | 2019 | |
| Sonex Health, INC. | $16.65 | 2025 | Sx-One Microknife |
| Glaxosmithkline, LLC. | $15.55 | 2024 | Shingrix, Arexvy |
| Takeda Pharmaceuticals U.S.A., INC. | $14.98 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $14.36 | 2023 | Rexulti |
| Sanofi-Aventis U.S. LLC | $13.91 | 2020 | |
| Axonics, INC. | $13.20 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $12.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Wood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.